newsfilter
← Latest News
GlobeNewswire·

Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections

NASHVILLE, Tenn., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America, today announced positive results from a prospective,